American HealthCare Capital is pleased to introduce a CLIA certified Pathology and Molecular Reference Lab for sale based in Florida. The lab specializes in Anatomic Pathology Testing and Molecular Testing, and they have recently started providing COVID-19 Testing. Although the company has largely been focused on Florida business to date, they are actively pursuing out of state referral sources and already have a small footprint in multiple states such as Georgia, Illinois, Michigan, and North Carolina.
The company’s payer mix is 50% Medicare and 50% private insurance. Gross revenues have grown exponentially since the company’s inception, reaching almost $1.5 million in 2019 with an adjusted EBITDA margin near 30%. In 2020, they are currently on pace to gross over $4 million with a similar EBITDA margin, and they are expected to be in the $6 – $7 million range in 2021.
This business opportunity includes the lab’s certifications, equipment, staff, and book of business. All serious offers will be considered.
If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.